Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss
Keywords:
spironolactone, hypotension, blood pressure monitoring, alopecia, androgenetic aloeciaReferences
Desai D, Nohria A, Sikora M, et al. Examining blood pressure changes with spironolactone for alopecia: A retrospective analysis. J Am Acad Dermatol. Published online August 27, 2024. doi:10.1016/j.jaad.2024.07.1523
Hill RC, Wang Y, Shaikh B, Ong M, Christos PJ, Lipner SR. Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study. J Am Acad Dermatol. 2024;90(6):1245-1247. doi:10.1016/j.jaad.2024.01.057
Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466-473. doi:10.1111/j.1365-2133.2005.06218.x
Burns LJ, De Souza B, Flynn E, Hagigeorges D, Senna MM. Spironolactone for treatment of female pattern hair loss. J Am Acad Dermatol. 2020;83(1):276-278. doi:10.1016/j.jaad.2020.03.087
James JF, Jamerson TA, Aguh C. Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review. J Am Acad Dermatol. 2022;86(2):425-429. doi:10.1016/j.jaad.2021.07.048
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Rachel C Hill, Yu Wang, Bilal Shaikh, Michael M. Ong, Paul J. Christos, Shari R. Lipner

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.